Daraprim — Blue Cross Blue Shield of Texas

Initial criteria

• The patient has an FDA approved indication for the requested agent AND
• The patient does NOT have any FDA labeled contraindications to the requested agent

Reauthorization criteria

• The patient was previously approved for the requested agent through the Prime Therapeutics Prior Authorization process in the previous 18 months

Approval duration

12 months